http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2308315-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-61
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
filingDate 1998-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f75bb7ba3e608bbc8b72ad7056b9d164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3bcfcf154eca5bb86616f2f3af7b304
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e2e656a1e9928075c4d509dc0513a79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fe0ce080f3fd0f7206de6b3c5431f17
publicationDate 1999-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2308315-A1
titleOfInvention N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
abstract The present invention relates to a compound of formula (I) wherein R1 and R2 are selected from lower alkyl groups having 1-6 carbon atoms, substituted or unsubstituted aryl groups, and unsaturated alkyl groups having 1-6 carbon atoms; R3 is a substituted or unsubstituted lower alkyl group having 1-6 carbons; and R4 is selected from substituted or unsubstituted lower alkyl groups having 1-6 carbon atoms, substituted or unsubstituted aryl groups, and unsaturated alkyl groups having 1-6 carbon atoms. The present invention also relates to a pharmaceutical composition comprising the above compound, as well as a method of treating tumor cells with the compound.
priorityDate 1997-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 27.